MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$8,467K
(9.23%↑ Y/Y)
Net loss
-$6,719K
(47.86%↑ Y/Y)
Other comprehensive
(loss)/income - foreign...
-$1,748K
(-149.11%↓ Y/Y)
Net loss before
income tax
-$6,719K
(47.86%↑ Y/Y)
Foreign currency
transaction gain/(loss),...
$1,628K
(158.88%↑ Y/Y)
Interest income
$327K
(-50.38%↓ Y/Y)
Benefit from research
and development tax...
$95K
(-48.65%↓ Y/Y)
Changes in the fair value
of warrants
$17K
(-95.91%↓ Y/Y)
Loss from operations
-$8,766K
(21.75%↑ Y/Y)
Interest expense
$20K
(-88.89%↓ Y/Y)
Research and development
$4,747K
(20.79%↑ Y/Y)
General and
administrative
$4,019K
(-44.73%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)